Sep 13, 2021 / 12:00PM GMT
Operator
Good morning and welcome to the AbbVie and REGENXBIO announce eye care collaboration conference call. (Operator Instructions) As a reminder, this conference call is being recorded.
I would now like to turn the call over to Mr. Patrick Christmas, Chief Legal Officer of REGENXBIO. You may begin.
Patrick J. Christmas - REGENXBIO Inc. - Senior VP & Chief Legal Officer
Good morning and thank you for joining us today. Speaking on behalf of REGENXBIO this morning is Ken Mills, REGENXBIO's President and Chief Executive Officer; joined by Vit Vasista, our Chief Financial Officer; Dr. Steve Pakola, our Chief Medical Officer; Curran Simpson, our Chief Operations and Technology Officer; and Ram Palanki, our Senior Vice President of Commercial Strategy and Operations, who will each be available for questions and answers.
Earlier this morning, REGENXBIO issued a press release announcing an eye care collaboration with AbbVie. This press release is available on our website at www.regenxbio.com<
Regenxbio Inc Call to Discuss Eye Care Collaboration with Abbvie Inc Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot